Phase II clinical trials of this inhibitor have been completed for patients with ovarian cancer and myelodysplastic syndrome (NCT01822691, NCT01685255)
Studies on human sleep behavior and chronic insomniac patients reveal that the peptide improves sleep architecture and sleep structure by promoting slow-wave (delta) sleep and supporting restorative, non-REM sleep (1)
The underlying mechanism (GHS release is somatostatin-feedback-governed, unlike exogenous rhGH) is sound, but claims that ipamorelin specifically "preserves pulsatility" are extrapolations from animal models, not findings from ipamorelin-specific research
Samples were subsequently analyzed for Glucose-6-phosphate and Fructose-6-phosphate levels following the manufacturers instructions respectively from MAK014 and MAK020 Assay Kits (Sigma)
Endurance athletes: Who need to delay fatigue and increase their energy
FAQ Some patients begin noticing reduced pain, improved mobility, and accelerated recovery within the first few weeks